Two Articles Written About Curis' Cancer Treatment By: MarketMinute.com Stock News September 03, 2009 at 17:12 PM EDT Two articles were published about Curis Inc.'s (Nasdaq: CRIS) experimental cancer treatment GDC-0449 sending the stock price up 31 cents to close at $2.41.